Bupleurum kaoi inhibits Coxsackie B virus type 1 infection of CCFS-1 cells by induction of type I interferons expression

Food and Chemical Toxicology

Volumn 45, Issue 1, 2007, Pages 24-31

  Cheng, Pei Wen ^a   Chiang, Lien Chai ^b   Yen, Ming Hong ^a   Lin, Chun Ching ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antiviral activity; Bupleurum kaoi (BK); Coxsackie B virus type 1 (CVB1); Interferon alpha beta (IFN )

Indexed keywords

HERBACEOUS AGENT; INTERFERON;

ANTIVIRAL ACTIVITY; ARTICLE; BUPLEURUM; BUPLEURUM KAOI; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; COXSACKIE VIRUS B; DRUG EFFECT; DRUG MECHANISM; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BUPLEURUM; CELL LINE; CELL SURVIVAL; CYTOPATHOGENIC EFFECT, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENTEROVIRUS B, HUMAN; FIBROBLASTS; HUMANS; INFANT, NEWBORN; INTERFERON-ALPHA; INTERFERON-BETA; MALE; NEUTRALIZATION TESTS; RIBAVIRIN; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); BUPLEURUM KAOI; HUMAN COXSACKIEVIRUS B1;

EID: 33751238186     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.06.007     Document Type: Article

References (37)

1. Amoros M., Fauconnier B., and Girre R.L. In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus. Antiviral Res. 8 (1987) 13-25
2. Bermejo P., Abad M.J., Diaz A.M., Fernandez L., Santos J.D., Sanchez S., Villaescusa L., Carrasco L., and Irurzun A. Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupleurum rigidum and Scrophularia scorodonia. Planta Med. 68 (2002) 106-110
3. Chebath J., Benech P., Revel M., and Vigneron M. Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330 (1987) 587-588
4. Chiang L.C., Chiang W., Chang S.F., and Chen H.Y. Spontaneous production of growth factors for human lymphocytes from a human papillomavirus type 18-contained foreskin fibroblast cell line. Gaoxiong Yi Xue Ke Xue Za Zhi 8 (1992) 121-126
5. Chiang L.C., Chiang W., Chang M.Y., Ng L.T., and Lin C.C. Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res. 55 (2002) 53-62
6. Chiang L.C., Ng L.T., Liu L.T., Shieh D.E., and Lin C.C. Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. Planta Med. 69 (2003) 705-709
7. Coccia E.M., Romeo G., Nissim A., Marziali G., Albertini R., Affabris E., Battistini A., Fiorucci G., Orsatti R., Rossi G.B., et al. A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology 179 (1990) 228-233
8. Deonarain R., Cerullo D., Fuse K., Liu P.P., and Fish E.N. Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110 (2004) 3540-3543
9. Foulis A.K., Farquharson M.A., Cameron S.O., McGill M., Schonke H., and Kandolf R. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia 33 (1990) 290-298
10. Galbraith D.N., Nairn C., and Clements G.B. Evidence for enteroviral persistence in humans. J. Gen. Virol. 78 Pt 2 (1997) 307-312
11. Heim A., Canu A., Kirschner P., Simon T., Mall G., Hofschneider P.H., and Kandolf R. Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. J. Infect. Dis. 166 (1992) 958-965
12. Hsu Y.L., Kuo P.L., Weng T.C., Yen M.H., Chiang L.C., and Lin C.C. The antiproliferative activity of saponin-enriched fraction from Bupleurum Kaoi is through Fas-dependent apoptotic pathway in human non-small cell lung cancer A549 cells. Biol. Pharm. Bull. 27 (2004) 1112-1115
13. Ida-Hosonuma M., Iwasaki T., Yoshikawa T., Nagata N., Sato Y., Sata T., Yoneyama M., Fujita T., Taya C., Yonekawa H., and Koike S. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 79 (2005) 4460-4469
14. Ito M., Nakashima H., Baba M., Pauwels R., De Clercq E., Shigeta S., and Yamamoto N. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]. Antiviral Res. 7 (1987) 127-137
15. Izumi S., Ohno N., Kawakita T., Nomoto K., and Yadomae T. Wide range of molecular weight distribution of mitogenic substance(s) in the hot water extract of a Chinese herbal medicine, Bupleurum chinese. Biol. Pharm. Bull. 20 (1997) 759-764
16. Jacobs B.L., and Langland J.O. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219 (1996) 339-349
17. Kandolf R., Klingel K., Zell R., Selinka H.C., Raab U., Schneider-Brachert W., and Bultmann B. Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology 35 (1993) 140-151
18. Lin C.C., Yen M.H., Chen J.Y., Chuang C.H., and Namba T. Anatomical and histological studies of Bupleuri radix. Am. J. Chin. Med. 19 (1991) 265-274
19. Matsumori A., Tomioka N., and Kawai C. Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice. Am. Heart J. 115 (1988) 1229-1232
20. Meurs E.F., Watanabe Y., Kadereit S., Barber G.N., Katze M.G., Chong K., Williams B.R., and Hovanessian A.G. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66 (1992) 5805-5814
21. Minnich L.L., and Ray C.G. Variable susceptibility of mice to group B coxsackievirus infections. J. Clin. Microbiol. 11 (1980) 73-75
22. Muir P., Nicholson F., Illavia S.J., McNeil T.S., Ajetunmobi J.F., Dunn H., Starkey W.G., Reetoo K.N., Cary N.R., Parameshwar J., and Banatvala J.E. Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy. Heart 76 (1996) 243-249
23. Munoz A., and Carrasco L. Action of human lymphoblastoid interferon on HeLa cells infected with RNA-containing animal viruses. J. Gen. Virol. 65 Pt 2 (1984) 377-390
24. Pfeffer L.M., Dinarello C.A., Herberman R.B., Williams B.R., Borden E.C., Bordens R., Walter M.R., Nagabhushan T.L., Trotta P.P., and Pestka S. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58 (1998) 2489-2499
25. Pistelli L., Bilia A.R., Marsili A., De Tommasi N., and Manunta A. Triterpenoid saponins from Bupleurum fruticosum. J. Nat. Prod. 56 (1993) 240-244
26. Ramsingh A.I., Chapman N., and Tracy S. Coxsackieviruses and diabetes. Bioessays 19 (1997) 793-800
27. Rao G.S., and Sinsheimer J.E. Antiviral activity of triterpenoid saponins containing acylated beta-amyrin aglycones. J. Pharm. Sci. 63 (1974) 471-473
28. Rodriguez J.E., Loepfe T.R., and Swack N.S. Beta interferon production in primed and unprimed cells infected with human cytomegalovirus. Arch. Virol. 94 (1987) 177-189
29. Samuel C.E. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183 (1991) 1-11
30. Sen G.C., and Lengyel P. The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267 (1992) 5017-5020
31. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
32. Toniolo A., Onodera T., Jordan G., Yoon J.W., and Notkins A.L. Virus-induced diabetes mellitus. Glucose abnormalities produced in mice by the six members of the Coxsackie B virus group. Diabetes 31 (1982) 496-499
33. Ushio Y., and Abe H. Inactivation of measles virus and herpes simplex virus by saikosaponin d. Planta Med. 58 (1992) 171-173
34. Yamaoka Y., Kawakita T., Kaneko M., and Nomoto K. A polysaccharide fraction of shosaiko-to active in augmentation of natural killer activity by oral administration. Biol. Pharm. Bull. 18 (1995) 846-849
35. Yokota S., Yokosawa N., Kubota T., Suzutani T., Yoshida I., Miura S., Jimbow K., and Fujii N. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage. Virology 286 (2001) 119-124
36. Yousef G.E., Isenberg D.A., and Mowbray J.F. Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis. Ann. Rheum. Dis. 49 (1990) 310-315
37. Zhou A., Paranjape J., Brown T.L., Nie H., Naik S., Dong B., Chang A., Trapp B., Fairchild R., Colmenares C., and Silverman R.H. Interferon action and apoptosis are defective in mice devoid of 2′, 5′-oligoadenylate-dependent RNase L. Embo J. 16 (1997) 6355-6363